[1]张永梅△ 张志敏 周洁 潘志兰 冯丽倩 杨彦.Ⅺ型胶原α1在多发性骨髓瘤中的表达及与预后的关系[J].中国中医骨伤科杂志,2022,30(08):56-60.
　ZHANG Yongmei ZHANG Zhimin ZHOU Jie PAN Zhilan FENG Liqian YANG Yan.Expression of Type Ⅺ Collagen α1 Chain in Multiple Myeloma and Its Relationship with Prognosis[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2022,30(08):56-60.
点击复制

Ⅺ型胶原α1在多发性骨髓瘤中的表达及与预后的关系()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第30卷
期数:
2022年08期
页码:
56-60
栏目:
临床研究
出版日期:
2022-08-15

文章信息/Info

Title:
Expression of Type Ⅺ Collagen α1 Chain in Multiple Myeloma and Its Relationship with Prognosis
文章编号:
1005-0205(2022)08-0056-05
作者:
张永梅1△ 张志敏1 周洁1 潘志兰1 冯丽倩1 杨彦1
1石家庄市人民医院血液内科(石家庄,050000)
Author(s):
ZHANG Yongmei1△ ZHANG Zhimin1 ZHOU Jie1 PAN Zhilan1 FENG Liqian1 YANG Yan1
1Department of Hematology,Shijiazhuang People's Hospital,Shijiazhuang 050000,China.
关键词:
多发性骨髓瘤;  预后;  临床特征;  生存时间;  Ⅺ型胶原α1
Keywords:
multiple myeloma;  prognosis;  clinical features;  survival time;  collagen type Ⅺ α1
分类号:
R738.1
文献标志码:
A
摘要:
目的:探讨Ⅺ型胶原α1(COL11A1)在多发性骨髓瘤中的表达及与患者预后的关系。方法:收集2012年1月至2018年3月初诊于本院小于65岁的多发性骨髓瘤患者100例为多发性骨髓瘤组,选择与其一般资料相匹配的50例健康骨髓捐献者作为对照组。采集受试者骨髓并分离单个核细胞,采用qRT-PCR法检测骨髓单个核细胞中COL11A1 mRNA水平; 采用Western Blot法检测骨髓单个核细胞中COL11A1蛋白表达水平; 收集患者临床病理资料,分析COL11A1表达水平与多发性骨髓瘤患者临床病理学指标的关系; 对患者随访3年,利用Kaplan-Meier法分析不同COL11A1表达水平与患者3年累积生存率的关系; 通过单因素和多因素COX回归分析影响多发性骨髓瘤患者预后的危险因素。结果:多发性骨髓瘤组患者骨髓单个核细胞中COL11A1 mRNA和蛋白表达水平均高于对照组,差异有统计学意义(P<0.05); 多发性骨髓瘤患者骨髓单个核细胞中COL11A1表达与性别、免疫球蛋白分型、轻链类型、血钙水平、血红蛋白水平、血肌酐水平、染色体状态无关,差异无统计学意义(P>0.05),与D-S分期、β2-微球蛋白水平、LDH水平、血清白蛋白水平有关,差异有统计学意义(P<0.05); Kaplan-Meier分析结果显示,COL11A1高表达组患者3年累积生存率(46.57%)显著低于低表达组(80.00%),差异有统计学意义(对数秩χ2=4.995,P=0.025); COX回归分析结果显示,COL11A1表达水平、D-S分期、ISS分期、β2-微球蛋白水平、血清白蛋白水平是影响患者预后的主要因素,差异有统计学意义(P<0.05),其中COL11A1高表达、D-S分期为Ⅱ+Ⅲ、ISS分期为Ⅱ+Ⅲ、β2-微球蛋白>3.5 mg/L、血清白蛋白>35 g/L是影响多发性骨髓瘤患者预后的危险因素,差异有统计学意义(P<0.05)。结论:COL11A1在多发性骨髓瘤患者骨髓单个核细胞中呈高表达,其表达水平与患者预后密切相关。
Abstract:
Objective:To investigate the expression of collagen type Ⅺ α1 chain(COL11A1)in multiple myeloma and its relationship with the prognosis of patients.Methods:100 multiple myeloma patients who were diagnosed in hospital during January 2012 to March 2018 and were younger than 65 years old were collected as the multiple myeloma group,and other 50 healthy bone marrow donors matching their general data were selected as the control group.The bone marrow of subjects was collected,and mononuclear cells were separated; qRT-PCR method was used to detect the level of COL11A1 mRNA in bone marrow mononuclear cells; Western Blot was used to detect the expression level of COL11A1 protein in bone marrow mononuclear cells; the clinical pathological data of patients were collected and the relationship between COL11A1 expression level and clinicopathological indicators of multiple myeloma patients was analyzed; the patients were followed up for 3 years.The Kaplan-Meier method was used to analyze the relationship between different COL11A1 expression levels and 3-year cumulative survival rate of patients; and univariate and multiva- riate COX regression analyses were used to analyze the risk factors that affected the prognosis of multiple myeloma patients.Results:The expression levels of COL11A1 mRNA and protein in bone marrow mononuclear cells of patients in the multiple myeloma group were higher than that in the control group,and the difference was statistically significant(P<0.05); the expression of COL11A1 in bone marrow mononuclear cells of patients with multiple myeloma had nothing to do with gender,immunoglobulin typing,light chain types,blood calcium level,hemoglobin level,blood creatinine level and chromosome status(P>0.05),but it was related to D-S staging,β2-microglobulin level,LDH level and serum albumin level(P<0.05).Kaplan-Meier analysis showed that the 3-year cumulative survival rate of patients in the COL11A1 high expression group(46.57%)was significantly lower than that in the low expression group(80.00%),and the difference was statistically significant(Log rank χ2=4.995,P=0.025); the results of COX regression analysis showed that COL11A1 expression level,D-S staging,ISS staging,β2-microglobulin level and serum albumin level were the main factors affecting the prognosis of patients(P<0.05),among which high expression of COL11A1,DS staging of stage Ⅱ+Ⅲ,ISS staging of stage Ⅱ+Ⅲ,β2-microglobulin >3.5 mg/L,serum albumin >35 g/L were the risk factors that affected the prognosis of multiple myeloma patients(P<0.05).Conclusion:COL11A1 is highly expressed in bone marrow mononuclear cells of patients with multiple myeloma,and its expression level is closely related to the prognosis of patients.

参考文献/References:

[1] 杨彦,潘志兰,张志敏.多发性骨髓瘤患者骨髓细胞周期素D1、D3、p21的表达及与预后的相关性研究[J].微循环学杂志,2021,31(3):58-62.
[2] 王卫国,冯玉虎,许凌云,等.多发性骨髓瘤患者CD200的表达及与预后的关系[J].现代肿瘤医学,2021,29(23):4205-4208.
[3] 陈黎.来那度胺联合硼替佐米治疗多发性骨髓瘤的疗效及对免疫相关细胞因子含量的影响[J].临床研究,2021,29(4):53-54.
[4] ZHANG W,CAO L,LIU X,et al.High expression of CHML predicts poor prognosis of multiple myeloma[J].J Cancer,2019,10(24):6048-6056.
[5] 徐玉红,张慧雅,郑伟平,等.miR-369-3p和COL11A1对卵巢癌细胞增殖迁移及侵袭的影响[J].中国妇幼保健,2021,36(18):4327-4331.
[6] ZHENG X,LIU X,ZHENG H,et al.Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma[J].Int Immunopharmacol,2021,90(8):106982.
[7] 中国多发性骨髓瘤工作组.中国多发性骨髓瘤诊治指南[J].中华内科杂志,2008,47(10):869-872.
[8] XIA B,WANG X,YANG R,et al.Epstein-Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma[J].Biosci Rep,2019,39(10):BSR20190284.
[9] 贺冠强,郭敏,索晓慧,等.lncRNA TUG1和PCAT-1表达水平与多发性骨髓瘤预后的关系及其诊断价值分析[J].国际检验医学杂志,2021,42(2):171-176.
[10] 范丹,肖方,及月茹,等.自体造血干细胞移植治疗多发性骨髓瘤疗效观察[J].海南医学,2021,32(20):2615-2618.
[11] 宁雪琴,魏小磊,郭绪涛,等.自体造血干细胞移植可改善多发性骨髓瘤患者的临床状态[J].南方医科大学学报,2021,41(9):1420-1425.
[12] ZHANG W,ZHANG Y,YANG Z,et al.High expression of UBE2T predicts poor prognosis and survival in multiple myeloma[J].Cancer Gene Ther,2019,26(11/12):347-355.
[13] 刘雪影,许良璧,李大欢,等.COL11A1在消化系统肿瘤中的研究进展[J].中华胃肠内镜电子杂志,2021,8(1):42-45.
[14] LI A,LI J,LIN J,et al.COL11A1 is overexpressed in gastric cancer tissues and regulates proliferation,migration and invasion of HGC-27 gastric cancer cells in vitro[J].Oncol Rep,2017,37(1):333-340.
[15] 穆速,李俊江,刘成远,等.COL11A1在结直肠癌组织的表达及其对其增殖、迁移和侵袭能力的影响[J].中华实验外科杂志,2021,38(6):1090-1092.
[16] 王霄飞,王梦扬,焦林杰,等.α1-Ⅺ型胶原蛋白基因突变对胃癌患者预后的影响及机制研究[J].中国现代普通外科进展,2021,24(8):630-639.
[17] 冯晓杰,李雷.干扰COL11A1基因表达对人卵巢癌细胞侵袭及耐药性影响[J].中华肿瘤防治杂志,2019,26(13):908-916.

备注/Memo

备注/Memo:
基金项目:河北省卫生健康委员会资助项目(20210067)
石家庄市卫生和计划生育委员会资助项目(20160803)
△通信作者 E-mail:zhangyongmei1986z@163.com
更新日期/Last Update: 2022-08-15